Cargando…

Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis

INTRODUCTION: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced safety surveillance (ESS) of seasonal influenza vaccines including a near real-time evaluation of collected data. The objective was to identify whether the use of passive surveillance or active surve...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Lusignan, Simon, Dos Santos, Gaël, Byford, Rachel, Schuind, Anne, Damaso, Silvia, Shende, Vishvesh, McGee, Chris, Yonova, Ivelina, Ferreira, Filipa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096981/ https://www.ncbi.nlm.nih.gov/pubmed/29995300 http://dx.doi.org/10.1007/s12325-018-0747-4

Ejemplares similares

Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
por: de Lusignan, Simon, et al.
Publicado: (2020)

Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis
por: Dos Santos, Gael, et al.
Publicado: (2019)

Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card
por: de Lusignan, Simon, et al.
Publicado: (2019)

Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season
por: Dos Santos, Gaël, et al.
Publicado: (2019)

Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
por: Dos Santos, Gael, et al.
Publicado: (2019)

Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England
por: de Lusignan, Simon, et al.
Publicado: (2017)

Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study
por: de Lusignan, Simon, et al.
Publicado: (2019)

Serological surveillance of influenza in an English sentinel network: pilot study protocol
por: de Lusignan, Simon, et al.
Publicado: (2019)

Conurbation, Urban, and Rural Living as Determinants of Allergies and Infectious Diseases: Royal College of General Practitioners Research and Surveillance Centre Annual Report 2016-2017
por: de Lusignan, Simon, et al.
Publicado: (2018)

Seasonal influenza: Modelling approaches to capture immunity propagation
por: Hill, Edward M., et al.
Publicado: (2019)

Impact of General Practitioner Education on Acceptance of an Adjuvanted Seasonal Influenza Vaccine among Older Adults in England
por: de Lusignan, Simon, et al.
Publicado: (2023)

Integrating molecular point-of-care testing for influenza into primary care: a mixed-methods feasibility study
por: de Lusignan, Simon, et al.
Publicado: (2020)

Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2019)

Incidence of Lower Respiratory Tract Infections and Atopic Conditions in Boys and Young Male Adults: Royal College of General Practitioners Research and Surveillance Centre Annual Report 2015-2016
por: de Lusignan, Simon, et al.
Publicado: (2018)

Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation
por: Hill, Edward M., et al.
Publicado: (2020)

Household presentation of influenza and acute respiratory illnesses to a primary care sentinel network: retrospective database studies (2013–2018)
por: de Lusignan, Simon, et al.
Publicado: (2020)

Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring
por: Dos Santos, Gaël, et al.
Publicado: (2023)

Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
por: Pebody, Richard, et al.
Publicado: (2016)

Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine
por: Domnich, Alexander, et al.
Publicado: (2023)

Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season
por: Dos Santos, Gaël, et al.
Publicado: (2021)

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
por: Thorrington, Dominic, et al.
Publicado: (2017)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
por: Ray, Riju, et al.
Publicado: (2017)

Safety Profile of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season
por: Salamanca de la Cueva, Ignacio, et al.
Publicado: (2021)

Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection
por: Kackos, Christina M., et al.
Publicado: (2023)

Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21
por: Syrkina, Olga, et al.
Publicado: (2022)

Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile
por: Correa, Ana, et al.
Publicado: (2016)

Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17
por: Pebody, Richard G, et al.
Publicado: (2018)

An Ontology to Improve Transparency in Case Definition and Increase Case Finding of Infectious Intestinal Disease: Database Study in English General Practice
por: de Lusignan, Simon, et al.
Publicado: (2017)

Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
por: Chabanon, Anne-Laure, et al.
Publicado: (2021)

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
por: Thommes, Edward W., et al.
Publicado: (2016)

Using an Ontology to Facilitate More Accurate Coding of Social Prescriptions Addressing Social Determinants of Health: Feasibility Study
por: Jani, Anant, et al.
Publicado: (2020)

Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
por: de Lusignan, Simon, et al.
Publicado: (2021)

Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season
por: Serradell, Laurence, et al.
Publicado: (2020)

Use and impact of social prescribing: a mixed-methods feasibility study protocol
por: Jani, Anant, et al.
Publicado: (2020)

The rationale for quadrivalent influenza vaccines
por: Ambrose, Christopher S., et al.
Publicado: (2012)

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany
por: Molnar, Daniel, et al.
Publicado: (2022)

End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal
por: Kislaya, Irina, et al.
Publicado: (2023)

An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
por: Urueña, Analia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5kui0gneaj8cusmpp1ekm0hamu